Market Cap (In USD)
1.91 Million
Revenue (In USD)
1.59 Million
Net Income (In USD)
48 Thousand
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-1.0E-4
- PE
- -
- EPS
- -
- Beta Value
- 63.153
- ISIN
- US30051V1061
- CUSIP
- 30051V106
- CIK
- 715788
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Lori Jean Glauser
- Employee Count
- -
- Website
- https://eviolabs.com
- Ipo Date
- 2004-01-21
- Details
- EVIO, Inc., together with its subsidiaries, provides analytical testing and advisory services to cannabis industry in the United States. The company's consulting services include advisory, product formulation, and licensing and compliance services. It also offers various testing services comprise cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, biological contaminant testing, and other services. EVIO, Inc. is headquartered in Henderson, Nevada.
More Stocks
-
300118Risen Energy Co.,Ltd.
300118
-
EEECoca-Cola HBC AG
EEE
-
BBN
-
SHLS
-
VWSB
-
HERDEZGrupo Herdez, S.A.B. de C.V.
HERDEZ
-
MURUDCERAMurudeshwar Ceramics Ltd.
MURUDCERA
-
1333